Teva Pharmaceutical Industries

NYSE: TEVA
$8.85
+$0.05 (+0.6%)
Closing price September 29, 2020
Thursday's top analyst upgrades and downgrades included Costco, Enphase Energy, Etsy, Moderna, Novavax, Regeneron Pharmaceuticals, Roku, Square, Teva Pharmaceutical, Wayfair and Zynga.
Monday's top analyst upgrades and downgrades included Amazon.com, Canopy Growth, CarMax, Chipotle Mexican Grill, Geron, Hess, Inogen, Occidental Petroleum, Snap, Teva Pharmaceutical, Vail Resorts and...
Amarin Corp. PLC (NASDAQ: AMRN) plans to mount a vigorous and speedy appeal of a U.S. District Court ruling that blocked its patents on the medication Vascepa, the company’s chief executive says....
Monday's top analyst upgrades and downgrades included Baker Hughes, Chewy, Chubb, eBay, Etsy, Gannett, GoDaddy, PayPal, Spotify, Southwest Airlines, Starbucks, Tesla and Zoom Communications.
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Ranging from very conservative to aggressive, these Raymond James health care stock picks are good additions to long-term portfolios looking to add or increase exposure to the sector.
See why Argus believes that Teva Pharmaceutical has made progress concerning its challenges, which are already baked into the stock price.
Tuesday's top analyst upgrades, downgrades and initiations included AbbVie, Apple, Arconic, CenturyLink, eHealth, Nvidia, Salesforce.com, Tesla and Teva Pharmaceutical.
Thursday's top analyst upgrades, downgrades and initiations included Applied Materials, Cisco Systems, Cognizant Technology Solutions, Costco Wholesale, Enphase Energy, Medtronic, Shopify, Starbucks,...
24/7 Wall St. has put together a preview of Cisco, Lyft, Nvidia and a few of the other most anticipated quarterly reports due this week.
Teva Pharmaceuticals has been under fire for its role in the opioid crisis and for pricing fixing of some drugs, often at many times their market value. Is there any sign of a turn around for this...
The January 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.